US 10577361
Dopamine D3 receptor antagonists having a morpholine moiety
granted A61PA61P25/18A61P25/30
Quick answer
US patent 10577361 (Dopamine D3 receptor antagonists having a morpholine moiety) held by Indivior UK Limited expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Indivior UK Limited
- Grant date
- Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P25/18, A61P25/30, A61P25/36